Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cannimed Therapeutics Inc (CMED.TO)

Cannimed Therapeutics Inc (CMED.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 668,430
  • Shares Outstanding, K 24,757
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.81
  • Price/Earnings ttm 158.82
  • Earnings Per Share ttm 0.17
  • Most Recent Earnings $0.22 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.00 unch
on 05/01/18
36.40 -25.82%
on 04/02/18
-9.22 (-25.46%)
since 03/29/18
3-Month
23.38 +15.48%
on 02/05/18
41.00 -34.15%
on 03/07/18
-3.00 (-10.00%)
since 02/01/18
52-Week
7.32 +268.85%
on 06/15/17
46.00 -41.30%
on 01/24/18
+15.91 (+143.46%)
since 05/01/17

Business Summary

CanniMed Therapeutics Inc is a biopharmaceutical company. The principal business activities of CanniMed along with its subsidiaries is plant biotechnology research, product development and the production of plant based materials.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 29.00
1st Resistance Point 28.00
Last Price 27.00
1st Support Level 26.50
2nd Support Level 26.00
3rd Support Level N/A

See More

52-Week High 46.00
Fibonacci 61.8% 31.22
Last Price 27.00
Fibonacci 50% 26.66
Fibonacci 38.2% 22.10
52-Week Low 7.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar